A Trial Assessing The Association Between Type Of Local Anesthesia Treatment And Postoperative Pain In Patients In Having Undergone Arrhythmia Surgery



Status:Active, not recruiting
Conditions:Post-Surgical Pain, Cardiology, Hospital
Therapuetic Areas:Cardiology / Vascular Diseases, Musculoskeletal, Other
Healthy:No
Age Range:18 - Any
Updated:1/20/2018
Start Date:November 2008
End Date:December 2019

Use our guide to learn which trials are right for you!

A DOUBLE-BLIND RANDOMIZED TRIAL ASSESSING THE ASSOCIATION BETWEEN TYPE OF LOCAL ANESTHESIA TREATMENT AND POSTOPERATIVE PAIN IN PATIENTS IN HAVING UNDERGONE ARRHYTHMIA SURGERY

The goal of the proposed study is to investigate the relationship between two standard
treatments, lidocaine or a mixture of lidocaine and bupivacaine, and 1) postoperative pain,
and; 2) narcotic use following pacemaker or defibrillator insertion in subjects who undergo
arrhythmia surgery at Baylor Heart and Vascular Institute while adjusting for pertinent
clinical and/or demographic factors. No control group is necessary.

Patients receiving a pacemaker or defibrillator are currently given Bupivacaine, Lidocaine,
or a mixture of the two for local anesthetic treatment (in addition to general anesthesia).
The choice of local anesthetic to be used during surgery is based primarily on the
differences in time for the anesthetic to take effect and duration thereafter. Lidocaine
typically works in less than 1 minute and lasts approximately 45 minutes. Bupivacaine works
within 2 to 3 minutes and lasts 4 to 6 hours. Lidocaine is often preferable due to its
shorter time of effectiveness. However, its relatively short duration may translate into a
higher use of narcotics for pain management during postoperative care - particularly within
the first hour following emergence from general anesthesia. Therefore it is conceivable that
these patients would have higher levels of pain, higher cost of care related to cost of
narcotics, and higher cost of caregiver time required to administer them.

Inclusion Criteria:

- Arrythmia patients receiving pacemaker or cardiac defibrillator devices at Baylor
Heart and Vascular Institute.

Exclusion Criteria:

- Receiving complicated procedures

- Replacement of parts, not inclusive of leads
We found this trial at
1
site
?
mi
from
Dallas, TX
Click here to add this to my saved trials